Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors
Not Applicable
Recruiting
- Conditions
- Acute liver failure.Fibrosis and cirrhosis of liver
- Registration Number
- IRCT20200928048867N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Recipients with acute liver failue and MELD score> 20 requiring urgent liver transplant
Recipients should have Negetive PCR test/ NO COVID-19 signs and symptoms/ NO lung involvement in HRCT
Deceased donors with positive PCR tests or COVID-19 lung involvement in HRCT
Exclusion Criteria
Recipients with clinical presentation of COVID-19 OR positive PCR test OR lung involvement in HRCT
Deceased donors due to respiratory failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Description of early outcomes of liver transplant from COVID-19 positive deceased donors. Timepoint: 30 days within operation. Method of measurement: Clinical assessments/ liver functional tests.;Evaluation of transmission of COVID-19. Timepoint: 24 hours, day 7 and 14 postoperatively. Method of measurement: Clinical manifestations, PCR test, lung HRCT.
- Secondary Outcome Measures
Name Time Method ong term outcomes of liver transplant from COVID-19 positive deceased donors. Timepoint: 6 months and 1 year postoperatively. Method of measurement: Clinical follow ups and liver function tests.